In contrast, distinct evidence underlined a correlation with tumor grade and stage [91]; moreover, Her-2 prevalence appears to be raised in patients with luminal subtypes and UTUC [92, 93], and its amplification might lead to lymphatic dissemination [94] and poor prognosis in UC [95]. This evidence concerns the gene ERBB2 and neoplasm.